Compounds > iridium
Page last updated: 2024-08-22

iridium and Angiogenesis, Pathologic

iridium has been researched along with Angiogenesis, Pathologic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albrecht, M; Brabec, V; Donnelly, K; Kasparkova, J; Mueller, T; Muenzner, JK; Novohradsky, V; Rehm, T; Schmitt, F; Schobert, R1
Bagowski, CP; Harms, K; Kräling, K; Meggers, E; Schmitz, DJ; Vlecken, DH; Wilbuer, A1
Di Fazio, P; Feng, L; Kastl, A; Meggers, E; Merkel, AL; Ocker, M; Wilbuer, A1

Other Studies

3 other study(ies) available for iridium and Angiogenesis, Pathologic

ArticleYear
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.
    Journal of inorganic biochemistry, 2016, Volume: 163

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chick Embryo; Gold; Humans; Imidazoles; Iridium; Melanoma; Mice; Neovascularization, Pathologic; Platinum; Ruthenium; Xenograft Model Antitumor Assays

2016
Iridium complex with antiangiogenic properties.
    Angewandte Chemie (International ed. in English), 2010, May-17, Volume: 49, Issue:22

    Topics: Animals; Coordination Complexes; Crystallography, X-Ray; Embryo, Nonmammalian; Humans; Iridium; Models, Animal; Molecular Conformation; Neovascularization, Pathologic; Oxidation-Reduction; Protein Kinase Inhibitors; Protein Kinases; Stereoisomerism; Vascular Endothelial Growth Factor Receptor-3; Zebrafish

2010
Dual anticancer activity in a single compound: visible-light-induced apoptosis by an antiangiogenic iridium complex.
    Chemical communications (Cambridge, England), 2012, Feb-11, Volume: 48, Issue:13

    Topics: Angiogenesis Inhibitors; Apoptosis; HeLa Cells; Humans; Iridium; Light; Neovascularization, Pathologic; Organometallic Compounds

2012